Asta Co Ltd is a Korea-based company mainly engaged in the manufacture and sale of mass spectrometry equipment. The Company is mainly engaged in the manufacture and sale of matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) based mass spectrometers and related consumables, which are mainly applied in display, secondary battery, and semiconductor industries.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

End-of-day quote Korea S.E. 2026-03-24			5-day change	1st Jan Change
6,070.00 ^KRW	-2.57%		-.--%	-26.60%

03-23	Asta wins 441 million won order	RE
02-24	ASTA Corporation announced that it expects to receive KRW 6 billion in funding from Samsung Securities Co.,Ltd., BOOKOOK Securities Co., Ltd., JB Woori Capital Co., Ltd.	CI

Market Cap	80.69B 114,327B 69.91B 65.5B 59.75B 112B 7,696B 114B 770B 301B 3,854B 303B 296B 12,850B	P/E 2021	-15.4x	P/E 2022	-17.8x
Enterprise Value	77.96B 110,464B 67.55B 63.29B 57.73B 109B 7,436B 110B 744B 291B 3,723B 293B 286B 12,416B	EV / Sales 2021	21.1x	EV / Sales 2022	14.4x
Free-Float	54.42%	Yield 2021 *	-	Yield 2022	-

03-23	Asta wins 441 million won order	RE
02-24	ASTA Corporation announced that it expects to receive KRW 6 billion in funding from Samsung Securities Co.,Ltd., BOOKOOK Securities Co., Ltd., JB Woori Capital Co., Ltd.	CI
02-24	ASTA Corporation announced that it has received KRW 10.464 billion in funding from SD Biosensor, Inc.	CI
02-09	ASTA Corporation announced that it expects to receive KRW 10.464 billion in funding from SD Biosensor, Inc.	CI
02-09	SD Biosensor, Inc. entered into a Share Purchase Agreement to acquire 27.19% stake in ASTA Corporation from Cho Eung-jun and Kim Yang-sun for KRW 32.8 billion.	CI
12-28	ASTA Corporation announced that it has received KRW 2.000664 billion in funding from Robots And Design Co., Ltd.	CI
12-18	ASTA Corporation announced that it expects to receive KRW 2.000664 billion in funding from Robots And Design Co., Ltd.	CI
25-09-29	ASTA Corporation announced that it has received KRW 2.0000304 billion in funding	CI
25-08-11	ASTA Corporation announced that it expects to receive KRW 2.0000304 billion in funding	CI
25-06-29	ASTA Corporation announced that it has received KRW 2.700036 billion in funding from KB Securities Co., Ltd.	CI
25-06-19	ASTA Corporation announced that it expects to receive KRW 2.700036 billion in funding	CI
25-03-09	ASTA Corporation announced that it has received KRW 3 billion in funding	CI
25-03-05	ASTA Corporation announced that it expects to receive KRW 3 billion in funding	CI

1 day	-2.57%
6 months	-21.98%
Current year	-26.60%

ASTA Corporation Stock

Stocks

A246720

KR7246720007

Medical Equipment, Supplies & Distribution

Valuation: ASTA Corporation

Chart: ASTA Corporation

Latest news : ASTA Corporation

Quotes and Performance

Course Extremes

Managers and Directors: ASTA Corporation

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Current year	5,900	11,080
1 year	5,530	11,080
3 years	3,810	12,120
5 years	3,060	13,050
10 years	2,780	29,500

Manager	Title	Age	Since
Eung-Jun Cho CEO	Chief Executive Officer	72	2005-12-31
Jong-Wan Park DFI	Director of Finance/CFO	56	2018-10-31
Yang-Sun Kim CEO	Chief Executive Officer	68	2005-12-31

Director	Title	Age	Since
Eung-Jun Cho CHM	Chairman	72	-
Eung-Soo Cho BRD	Director/Board Member	70	2015-11-30
Chul-Woo Park BRD	Director/Board Member	73	2022-03-28

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ASTA CORPORATION	-2.57%	-.--%	-2.41%	-31.26%	70.18M
ABBOTT LABORATORIES	+1.08%	+4.92%	-15.35%	+5.32%	192B
MEDTRONIC PLC	+0.09%	+5.55%	-1.43%	+8.76%	116B
CENCORA, INC.	-5.90%	-0.96%	+8.65%	+67.67%	59.95B
HOYA CORPORATION	+2.11%	+4.26%	+33.94%	+64.61%	54.64B
BECTON, DICKINSON AND COMPANY	+1.20%	+7.57%	-5.84%	-34.97%	50B
DEXCOM, INC.	+1.42%	+9.85%	+13.26%	-18.70%	34.26B
MEDLINE INC.	+1.31%	-3.18%	-	-	31.15B
WEST PHARMACEUTICAL SERVICES, INC.	+0.26%	+0.36%	+46.85%	-10.75%	24.79B
TERUMO CORPORATION	+0.85%	+13.34%	-6.26%	+23.46%	24.07B
Average	-0.01%	+2.68%	+7.93%	+8.24%	58.7B
Weighted average by Cap.	+0.26%	+4.27%	+0.78%	+13.55%

	2021	2022
Net sales	2.56B 3,633B 2.22B 2.08B 1.9B 3.57B 245B 3.62B 24.48B 9.57B 122B 9.63B 9.42B 408B	3.35B 4,740B 2.9B 2.72B 2.48B 4.66B 319B 4.73B 31.94B 12.49B 160B 12.56B 12.29B 533B
Net income	-3.53B -5,004B -3.06B -2.87B -2.62B -4.92B -337B -4.99B -33.72B -13.18B -169B -13.26B -12.97B -562B	-2.8B -3,966B -2.43B -2.27B -2.07B -3.9B -267B -3.96B -26.73B -10.45B -134B -10.51B -10.28B -446B
Net Debt	-5.5B -7,793B -4.77B -4.47B -4.07B -7.66B -525B -7.77B -52.52B -20.53B -263B -20.65B -20.2B -876B	-2.73B -3,863B -2.36B -2.21B -2.02B -3.8B -260B -3.85B -26.03B -10.18B -130B -10.24B -10.01B -434B